Deutsch English Français

Contact

EP2699246

European procedure

Unitary Patent

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2699246

EP2699246 - METHOD OF INHIBITING HARMFUL MICROORGANISMS AND BARRIER-FORMING COMPOSITION THEREFOR [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 19.04.2024 Database last updated on 23.04.2024
Former	The patent has been granted Status updated on 12.05.2023
Former	Grant of patent is intended Status updated on 11.01.2023
Former	Examination is in progress Status updated on 09.05.2018
Most recent event Tooltip	19.04.2024	No opposition filed within time limit	published on 22.05.2024 [2024/21]
Applicant(s)	For all designated states Arms Pharmaceutical LLC. 812 Huron Road (Caxton Building), Suite 235 Cleveland, OH 44115 / US
	[2014/09]
Inventor(s)	01 / SOKOL, Brian 333 Grand Harbour Vermillion, OH 44089 / US
	02 / GHANNOUM, Afif 3695 Tolland Road Shaker Heights, OH 44122 / US
	[2023/06]
Former [2014/09]	01 / SOKOL, Brian 333 Grand Harbour Vermillion, OH 44089 / US
Representative(s)	Tostmann, Holger Carl Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB Zweibrückenstrasse 5-7 80331 München / DE
	[2023/24]
Former [2014/09]	Tostmann, Holger Carl Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Zweibrückenstrasse 5-7 80331 München / DE
Application number, filing date	12774888.7	17.04.2012
	[2023/24]
	WO2012US33921
Priority number, date	US201161477147P	19.04.2011 Original published format: US 201161477147 P
	[2014/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012145307
	Date:	26.10.2012
	Language:	EN
	[2012/43]
	Type:	A1 Application with search report
	No.:	EP2699246
	Date:	26.02.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.10.2012 takes the place of the publication of the European patent application.
	[2014/09]
	Type:	B1 Patent specification
	No.:	EP2699246
	Date:	14.06.2023
	Language:	EN
	[2023/24]
Search report(s)	International search report - published on:	RU	26.10.2012
	(Supplementary) European search report - dispatched on:	EP	08.09.2014
Classification	IPC:	A61K9/08, A61K47/36, A61K31/736, A61K31/047, A61K31/155, A61P31/02, A61P39/00	[2022/51]
	CPC:	A61K9/006 (EP,US); A61K31/736 (KR); A61K31/047 (KR); A61K31/155 (EP,KR,US); A61K31/4425 (EP,US); A61P1/02 (EP); (+) A61P11/02 (EP); A61P11/04 (EP); A61P31/00 (EP); A61P31/02 (EP); A61P31/04 (EP); A61P31/12 (EP); A61P39/00 (EP); A61P43/00 (EP); Y02A50/30 (EP) (-)
	Former IPC [2014/41]	A61K31/736, A61K31/047, A61K31/155, A61P31/02, A61P39/00, A61K9/00, A61K47/10, A61K47/36
	Former IPC [2014/09]	A61K31/736, A61K31/047, A61K31/155, A61P31/02, A61P39/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/09]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	VERFAHREN ZUR HEMMUNG SCHÄDLICHER MIRKOORGANISMEN UND BARRIEREFORMENDE ZUSAMMENSETZUNG DAFÜR	[2014/09]
	English:	METHOD OF INHIBITING HARMFUL MICROORGANISMS AND BARRIER-FORMING COMPOSITION THEREFOR	[2014/09]
	French:	PROCÉDÉ D'INHIBITION DE MICROORGANISMES DANGEREUX ET COMPOSITION FORMANT BARRIÈRE POUR LE METTRE EN UVRE	[2014/09]
Entry into regional phase	07.11.2013	National basic fee paid
	07.11.2013	Search fee paid
	07.11.2013	Designation fee(s) paid
	07.11.2013	Examination fee paid
Examination procedure	07.11.2013	Examination requested [2014/09]
	02.04.2015	Amendment by applicant (claims and/or description)
	17.02.2016	Despatch of a communication from the examining division (Time limit: M06)
	28.06.2016	Reply to a communication from the examining division
	02.05.2018	Despatch of a communication from the examining division (Time limit: M04)
	30.08.2018	Reply to a communication from the examining division
	07.05.2020	Despatch of a communication from the examining division (Time limit: M04)
	17.08.2020	Reply to a communication from the examining division
	16.11.2022	Cancellation of oral proceeding that was planned for 18.11.2022
	18.11.2022	Date of oral proceedings (cancelled)
	12.01.2023	Communication of intention to grant the patent
	09.05.2023	Fee for grant paid
	09.05.2023	Fee for publishing/printing paid
	09.05.2023	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.02.2016
Opposition(s)	15.03.2024	No opposition filed within time limit [2024/21]
Fees paid	Renewal fee
	31.03.2014	Renewal fee patent year 03
	29.04.2015	Renewal fee patent year 04
	31.03.2016	Renewal fee patent year 05
	28.04.2017	Renewal fee patent year 06
	26.04.2018	Renewal fee patent year 07
	30.04.2019	Renewal fee patent year 08
	30.04.2020	Renewal fee patent year 09
	22.04.2021	Renewal fee patent year 10
	25.04.2022	Renewal fee patent year 11
	18.04.2023	Renewal fee patent year 12
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CZ	14.06.2023
	ES	14.06.2023
	HR	14.06.2023
	PL	14.06.2023
	RO	14.06.2023
	RS	14.06.2023
	SK	14.06.2023
	SM	14.06.2023
	NO	14.09.2023
	GR	15.09.2023
	IS	14.10.2023
	[2024/10]
Former [2024/08]	ES	14.06.2023
	HR	14.06.2023
	RS	14.06.2023
	SK	14.06.2023
	SM	14.06.2023
	NO	14.09.2023
	GR	15.09.2023
Former [2023/51]	ES	14.06.2023
	HR	14.06.2023
	RS	14.06.2023
	NO	14.09.2023
	GR	15.09.2023
Former [2023/50]	ES	14.06.2023
	NO	14.09.2023
	GR	15.09.2023
Former [2023/48]	ES	14.06.2023
	NO	14.09.2023
Former [2023/46]	ES	14.06.2023
Documents cited:	Search	[XI]US4657758 (GOLDEMBERG ROBERT L [US], et al) [X] 1-8,10-15 * column 5, line 42 - line 43 * * example 1 * [I] 9;
		[XI]WO2004045572 (J P M E D LTD [IL], et al) [X] 1-8,10-15 * page 8, line 8 - line 13 * * page 9, line 12 - line 23 * * page 13, line 9 - line 12 * * example 2 * [I] 9;
		[XI]US2007166244 (GHOSH CHANCHAL K [US], et al) [X] 1-8,10-15 * paragraph [0001] * * paragraph [0054] - paragraph [0055] * * example 4 *[I] 9;
		[XI]EP2100590 (SUNSTAR INC [JP]) [X] 1-8,10-15 * paragraph [0017] - paragraph [0024] * * paragraph [0045] - paragraph [0046] * [I] 9;
		[XI]US2009238777 (JOZIAK MARILOU [US], et al) [X] 1-8,10-15 * paragraph [0038] - paragraph [0039] * * paragraph [0052] - paragraph [0053] * * example 1 * [I] 9
	International search	[X]US6749869 (RICHTER FRANCIS L [US], et al);
		[X]RU2302865 (KOLI FARMAS JUTIKAL GMBKH [DE]);
		[X]US2008206155 (TAMARKIN DOV [IL], et al);
		[A]US2008255498 (HOULE PHILIP R [US])
	Examination	- BALAKRISHNAN M ET AL, "Dental caries is a preventable infectious disease.", AUSTRALIAN DENTAL JOURNAL DEC 2000, (200012), vol. 45, no. 4, ISSN 0045-0421, pages 235 - 245
		- CAUFIELD PAGE W ET AL, "Dental caries: an infectious and transmissible disease.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (200505), Database accession no. NLM17036539
		- COMPENDIUM OF CONTINUING EDUCATION IN DENTISTRY (JAMESBURG, N.J. : 1995) MAY 2005, (200505), vol. 26, no. 5 Suppl 1, ISSN 1548-8578, pages 10 - 16
	by applicant	US4657758
		WO2004045572
		US6749869
		RU2004132209
		US2007166244
		US2008206155
		US2008255498
		EP2100590
		US2009238777
		- MONICA BOIRIVANTAWARREN STROBER, "The Mechanism of Action of Probiotics", Current Opinion in Gastroenterology, (20070000), vol. 23, pages 679 - 692
		- "Gastrointestinal mucosal injury in experimental models of shock, trauma, and sepsis", Crit. Care Med., (19910000), vol. 19, pages 627 - 41
		- ANDERS HEIMDAHL, "Prevention and Management of Oral Infections in Cancer Patients", Supportive Care in Cancer, (19990000), vol. 7, no. 4, doi:10.1007/s005200050253, pages 224 - 228, XP037076881 DOI: http://dx.doi.org/10.1007/s005200050253
		- SHAHAB A. KHANJOHN R. WINGARD, "Infection and Mucosal Injury", Cancer Treatment Journal of the National Cancer Institute, (20010000), no. 29
		- FRANK-ALBERT PITTENAXEL KRAMER, "Efficacy of Cetylpyridinium Chloride Used as Oropharyngeal Antiseptic", Arzneim.-Forsch./Drug Res, (20010000), vol. 51, no. II, doi:10.1055/s-0031-1300084, pages 588 - 595, XP001537477 DOI: http://dx.doi.org/10.1055/s-0031-1300084
		- CHANDRA et al., "In vitro Growth and Analysis of Candida Biofilms", Nature Protocols, (20080000), vol. 3, no. 12, pages 1909 - 1924

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p